About: sulfadoxine/pyrimethamine

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: sulfadoxine/pyrimethamine Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

combination drug

Attributes	Values
rdf:type	Item
description	Kombinationspräparat (de) combination drug (en) temel ilaç (tr) association médicamenteuse (fr) medicamento combinado (es) ଏହା ଏକ ଯୁଗ୍ମ ଔଷଧ ଯାହା ମ୍ୟାଲେରିଆ ରୋଗର ଚିକିତ୍ସା ପାଇଁ ଦିଆଯାଏ । (or) läkemedel bestående av två aktiva farmaceutiska substanser (sv)
rdfs:label	Associação sulfadoxina/pirimetamina (pt) ସଲଫାଡକ୍‌ସିନ/ପାଇରିମେଥାମିନ (or) Sulfadoksin + Pirimetamin (tr) Sulfadoxin/pyrimethamin (sv) Sulfadoxina/pirimetamina (es) Sulfadoxine/pyrimethamine (vi) sulfadoxine/pyrimethamine (en) σουλφαδοξίνη/πυριμεθαμίνη (el) Піріметамін/сульфадоксин (uk) سلفادوكسين/بيرميثامين (ar) スルファドキシン／ピリメサミン (ja) 周效磺胺/比利美胺 (zh)
skos:prefLabel	Associação sulfadoxina/pirimetamina (pt) ସଲଫାଡକ୍‌ସିନ/ପାଇରିମେଥାମିନ (or) Sulfadoksin + Pirimetamin (tr) Sulfadoxin/pyrimethamin (sv) Sulfadoxina/pirimetamina (es) Sulfadoxine/pyrimethamine (vi) sulfadoxine/pyrimethamine (en) σουλφαδοξίνη/πυριμεθαμίνη (el) Піріметамін/сульфадоксин (uk) سلفادوكسين/بيرميثامين (ar) スルファドキシン／ピリメサミン (ja) 周效磺胺/比利美胺 (zh)
name	Associação sulfadoxina/pirimetamina (pt) ସଲଫାଡକ୍‌ସିନ/ପାଇରିମେଥାମିନ (or) Sulfadoksin + Pirimetamin (tr) Sulfadoxin/pyrimethamin (sv) Sulfadoxina/pirimetamina (es) Sulfadoxine/pyrimethamine (vi) sulfadoxine/pyrimethamine (en) σουλφαδοξίνη/πυριμεθαμίνη (el) Піріметамін/сульфадоксин (uk) سلفادوكسين/بيرميثامين (ar) スルファドキシン／ピリメサミン (ja) 周效磺胺/比利美胺 (zh)
Freebase ID	wds:Q7636174-70A8DFA3-9885-4033-B040-B3DF28FB1A58
Freebase ID	/m/0h3mk1j
pregnancy category	wds:Q7636174-2CF4A781-0BCE-4FD6-94F7-B4BD8F3E1652 wds:Q7636174-9B8312C7-B169-495A-AD40-3520821B7251
pregnancy category	US pregnancy category C Australian pregnancy category C
instance of	wds:Q7636174-63003A7F-3825-44C2-B239-599923985860 wds:Q7636174-7ef377c6-4133-3bd8-c1ba-fbaf3f97f3d3
instance of	combination drug essential medicine
has part(s)	wds:Q7636174-225f2f62-4008-96b9-2b6e-4c6a911d03d6 wds:Q7636174-c223f320-41d6-e5c2-bbc5-dd60277484ca
has part(s)	sulfadoxine wd:Q421072
skos:altLabel	Fansidar (or) sulfadoxina/pirimetamina (pt) スルファドキシン/ピリメタミン (ja) 磺胺多辛/乙胺嘧啶 (zh)
Microsoft Academic ID	wds:Q7636174-396903C9-245B-48DF-A26F-C224DDDD5458
Microsoft Academic ID	https://makg.org/entity/2780441369
Microsoft Academic ID	2780441369
WikiProjectMed ID	wds:Q7636174-15EFA3BD-E9A3-41E1-98CA-AA661FC924FB
WikiProjectMed ID	Sulfadoxine/pyrimethamine
electronic Essenti... List medicine ID	wds:Q7636174-90784291-3C0B-435B-A722-B523D3D24851
electronic Essenti... List medicine ID	382
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q7636174 Sulfadoxine/pyrimethamine https://ja.wikipedia.org/wiki/%E3%82%B9%E3%83%AB%E3%83%95%E3%82%A1%E3%83%89%E3%82%AD%E3%82%B7%E3%83%B3%E3%83%BB%E3%83%94%E3%83%AA%E3%83%A1%E3%82%BF%E3%83%9F%E3%83%B3 https://or.wikipedia.org/wiki/%E0%AC%B8%E0%AC%B2%E0%AC%AB%E0%AC%BE%E0%AC%A1%E0%AC%95%E0%AD%8D%E2%80%8C%E0%AC%B8%E0%AC%BF%E0%AC%A8/%E0%AC%AA%E0%AC%BE%E0%AC%87%E0%AC%B0%E0%AC%BF%E0%AC%AE%E0%AD%87%E0%AC%A5%E0%AC%BE%E0%AC%AE%E0%AC%BF%E0%AC%A8 https://ar.wikipedia.org/wiki/%D8%B3%D9%84%D9%81%D8%A7%D8%AF%D9%88%D9%83%D8%B3%D9%8A%D9%86/%D8%A8%D9%8A%D8%B1%D9%85%D9%8A%D8%AB%D8%A7%D9%85%D9%8A%D9%86 https://es.wikipedia.org/wiki/Sulfadoxina/pirimetamina https://fa.wikipedia.org/wiki/%D8%B3%D9%88%D9%84%D9%81%D8%A7%D8%AF%D9%88%DA%A9%D8%B3%DB%8C%D9%86/%D9%BE%DB%8C%D8%B1%DB%8C%D9%85%D8%AA%D8%A7%D9%85%DB%8C%D9%86 https://pt.wikipedia.org/wiki/Associa%C3%A7%C3%A3o_sulfadoxina/pirimetamina https://uk.wikipedia.org/wiki/%D0%9F%D1%96%D1%80%D0%B8%D0%BC%D0%B5%D1%82%D0%B0%D0%BC%D1%96%D0%BD/%D1%81%D1%83%D0%BB%D1%8C%D1%84%D0%B0%D0%B4%D0%BE%D0%BA%D1%81%D0%B8%D0%BD https://vi.wikipedia.org/wiki/Sulfadoxine/pyrimethamine
is has part(s) of	World Health Organization Model List of Essential Medicines
is main subject of	Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005 Development of resistance by Plasmodium falciparum to sulfadoxine/pyrimethamine in Amhara Region, Northwestern Ethiopia. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial Mefloquine and sulfadoxine/pyrimethamine overdose in malaria tropica High prevalence of mutations in the dihydrofolate reductase gene of Plasmodium falciparum in isolates from Tanzania without evidence of an association to clinical sulfadoxine/pyrimethamine resistance. Impact of folate supplementation on the efficacy of sulfadoxine/pyrimethamine in preventing malaria in pregnancy: the potential of 5-methyl-tetrahydrofolate RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia In vivo response of multi-resistant Plasmodium falciparum infections to mefloquine and its combination with sulfadoxine/pyrimethamine in Cambodia. Artesunate plus sulfadoxine/pyrimethamine versus praziquantel in the treatment of Schistosoma mansoni in eastern Sudan Amodiaquine combined with sulfadoxine/pyrimethamine versus artemisinin-based combinations for the treatment of uncomplicated falciparum malaria in Africa: a meta-analysis. Efficacy of sulfadoxine/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in Republic of Congo. Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea. Efficacy of chloroquine and sulfadoxine/pyrimethamine mono- and combined therapy against falciparum malaria in Sudan. Comparison of different artemisinin-based combinations for the treatment of Plasmodium falciparum malaria in children in Kigali, Rwanda, an area of resistance to sulfadoxine-pyrimethamine: artesunate plus sulfadoxine/pyrimethamine versus artesunate

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 182 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software